novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

4 Outubro 2017

Ver apresentação completa

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

4 Outubro 2017
0

2017 ESC/EACTS Guidelines for the management of valvular heart disease

4 Outubro 2017
0

-->